LAVA Therapeutics NV Net Asset Momentum
LAVA Therapeutics NV net asset momentum. LAVA Therapeutics NV (LVTX) recorded a net asset momentum of -45.8% as of December 2024, with net assets of $27.75 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore LAVA Therapeutics NV (LVTX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of LAVA Therapeutics NV (2019–2024)
Net asset momentum of LAVA Therapeutics NV from 2019 to 2024. This chart tracks LAVA Therapeutics NV's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -45.8%, with net assets of $27.75 Million USD as of December 2024. See LVTX net assets for net asset value and shareholders' equity analysis.
LAVA Therapeutics NV Net Asset Momentum by Year (2019–2024)
LAVA Therapeutics NV net asset momentum by year from 2019 to 2024. The table below shows the complete annual net asset history for LAVA Therapeutics NV from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see LAVA Therapeutics NV (LVTX) total market value.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $27.75 Million | $80.83 Million | $53.09 Million | ▼ -45.8% |
| 2023 | $51.18 Million | $101.71 Million | $50.53 Million | ▼ -40.5% |
| 2022 | $86.04 Million | $143.43 Million | $57.38 Million | ▼ -27.3% |
| 2021 | $118.37 Million | $139.25 Million | $20.88 Million | ▲ +1453.2% |
| 2020 | $7.62 Million | $20.49 Million | $12.87 Million | ▲ +30.4% |
| 2019 | $5.84 Million | $8.80 Million | $2.95 Million | — |